Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 3 | 2018 | 413 | 1.050 |
Why?
|
| Fibromyalgia | 2 | 2017 | 29 | 0.990 |
Why?
|
| Electroconvulsive Therapy | 5 | 2018 | 402 | 0.830 |
Why?
|
| Pulmonary Edema | 1 | 2018 | 37 | 0.620 |
Why?
|
| Amantadine | 1 | 2017 | 8 | 0.580 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2017 | 12 | 0.580 |
Why?
|
| Depressive Disorder, Major | 3 | 2018 | 439 | 0.580 |
Why?
|
| Catatonia | 1 | 2017 | 20 | 0.580 |
Why?
|
| Dopamine Agents | 1 | 2017 | 56 | 0.570 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 109 | 0.560 |
Why?
|
| Medication Adherence | 2 | 2017 | 335 | 0.560 |
Why?
|
| Delirium | 1 | 2017 | 45 | 0.560 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 106 | 0.550 |
Why?
|
| Depression | 3 | 2016 | 943 | 0.550 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 649 | 0.510 |
Why?
|
| Phototherapy | 1 | 2014 | 28 | 0.480 |
Why?
|
| Electric Stimulation Therapy | 3 | 2016 | 147 | 0.480 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 81 | 0.470 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 435 | 0.460 |
Why?
|
| Suicide | 1 | 2014 | 116 | 0.440 |
Why?
|
| Affect | 1 | 2014 | 218 | 0.430 |
Why?
|
| Depressive Disorder | 2 | 2016 | 621 | 0.430 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 1506 | 0.290 |
Why?
|
| Vagus Nerve | 1 | 2007 | 90 | 0.270 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 142 | 0.260 |
Why?
|
| Psychotic Disorders | 2 | 2017 | 157 | 0.260 |
Why?
|
| Cognition Disorders | 2 | 2016 | 342 | 0.250 |
Why?
|
| Inpatients | 2 | 2015 | 208 | 0.220 |
Why?
|
| Psychiatry | 2 | 2014 | 112 | 0.220 |
Why?
|
| Parkinson Disease | 2 | 2016 | 272 | 0.210 |
Why?
|
| Humans | 17 | 2022 | 68618 | 0.200 |
Why?
|
| Adult | 8 | 2018 | 21403 | 0.200 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 79 | 0.200 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 438 | 0.190 |
Why?
|
| Aged | 7 | 2017 | 14862 | 0.180 |
Why?
|
| Middle Aged | 8 | 2017 | 21147 | 0.160 |
Why?
|
| Prefrontal Cortex | 2 | 2016 | 640 | 0.160 |
Why?
|
| Male | 9 | 2018 | 37321 | 0.160 |
Why?
|
| Mental Disorders | 2 | 2014 | 659 | 0.160 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2017 | 9 | 0.150 |
Why?
|
| Pregabalin | 1 | 2017 | 13 | 0.150 |
Why?
|
| Venlafaxine Hydrochloride | 1 | 2017 | 42 | 0.140 |
Why?
|
| Neurosyphilis | 1 | 2016 | 7 | 0.140 |
Why?
|
| Bipolar Disorder | 2 | 2016 | 307 | 0.140 |
Why?
|
| Dura Mater | 1 | 2016 | 23 | 0.140 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2016 | 29 | 0.130 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 53 | 0.130 |
Why?
|
| Female | 8 | 2018 | 38074 | 0.130 |
Why?
|
| Deep Brain Stimulation | 1 | 2015 | 71 | 0.120 |
Why?
|
| Adolescent | 3 | 2017 | 8912 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2015 | 86 | 0.120 |
Why?
|
| Health Care Costs | 1 | 2017 | 346 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2017 | 622 | 0.120 |
Why?
|
| Seizures | 1 | 2016 | 279 | 0.120 |
Why?
|
| Specialization | 1 | 2014 | 66 | 0.120 |
Why?
|
| Reward | 1 | 2015 | 201 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2016 | 1342 | 0.110 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 102 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2223 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 951 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2017 | 2358 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 772 | 0.090 |
Why?
|
| Curriculum | 1 | 2014 | 575 | 0.090 |
Why?
|
| Young Adult | 3 | 2016 | 5717 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2016 | 7029 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 931 | 0.080 |
Why?
|
| Brain | 2 | 2022 | 2176 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2014 | 596 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2017 | 7277 | 0.070 |
Why?
|
| Neuropsychology | 1 | 2007 | 11 | 0.070 |
Why?
|
| Time Factors | 1 | 2014 | 4655 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 782 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2022 | 532 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 4848 | 0.030 |
Why?
|
| Epidural Space | 1 | 2016 | 15 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 127 | 0.030 |
Why?
|
| Subthalamic Nucleus | 1 | 2015 | 16 | 0.030 |
Why?
|
| Electrodes | 1 | 2016 | 147 | 0.030 |
Why?
|
| Apathy | 1 | 2015 | 28 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 248 | 0.030 |
Why?
|
| Hospitals, Psychiatric | 1 | 2015 | 59 | 0.030 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2015 | 88 | 0.030 |
Why?
|
| Anesthesia | 1 | 2016 | 120 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2015 | 294 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 3259 | 0.020 |
Why?
|